🇺🇸 paricalcitol capsule in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Asthenia — 1 report (10%)
2. Atrial Fibrillation — 1 report (10%)
3. Back Pain — 1 report (10%)
4. Bowel Movement Irregularity — 1 report (10%)
5. Compression Fracture — 1 report (10%)
6. Confusional State — 1 report (10%)
7. Decreased Activity — 1 report (10%)
8. Disorientation — 1 report (10%)
9. Dizziness — 1 report (10%)
10. Drug Dose Omission — 1 report (10%)

Source database →

Frequently asked questions

Is paricalcitol capsule approved in United States?

paricalcitol capsule does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for paricalcitol capsule in United States?

Abbott is the originator. The local marketing authorisation holder may differ — check the official source linked above.